These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2. Ayachit AG; Reddy LU; Joshi S; Ayachit GS Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674 [TBL] [Abstract][Full Text] [Related]
3. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography. Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482 [TBL] [Abstract][Full Text] [Related]
5. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography. Pauleikhoff D; Gunnemann F; Book M; Rothaus K Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765 [TBL] [Abstract][Full Text] [Related]
6. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2. Au A; Hou K; Baumal CR; Sarraf D JAMA Ophthalmol; 2018 Oct; 136(10):1182-1185. PubMed ID: 30054619 [TBL] [Abstract][Full Text] [Related]
7. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia? Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography. Park YG; Park YH PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375 [TBL] [Abstract][Full Text] [Related]
9. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2. Dogan B; Erol MK; Akidan M; Suren E; Akar Y Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862 [TBL] [Abstract][Full Text] [Related]
11. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9. Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659 [TBL] [Abstract][Full Text] [Related]
12. Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia. Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S Eye (Lond); 2022 Aug; 36(8):1623-1630. PubMed ID: 34326496 [TBL] [Abstract][Full Text] [Related]
13. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging. Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211 [TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study. Singh SR; Fraser-Bell S; Dogra A; Sahoo NK; Gabrielle PH; Lupidi M; Al-Sheikh M; Borrelli E; Sacconi R; Querques G; Chhablani J Eur J Ophthalmol; 2021 Jul; 31(4):1933-1939. PubMed ID: 32613846 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography. Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394 [TBL] [Abstract][Full Text] [Related]
16. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density. Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628 [TBL] [Abstract][Full Text] [Related]